Orthopedic Biomaterials | Europe | 2016 | Market Analysis
New product releases in the BGS market as well as favorable demographics will continue to drive moderate procedure growth and offset downward pricing pressures in the orthopedic biomaterial market. Nevertheless, economic difficulties, negative publicity for some products, as well as variable reimbursement will remain limiting factors in this space.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for orthopedic biomaterials in Europe across a 10-year period.